Jeanelle Kam
Clinical Pharmacology · Dallas, TXNPI 1104975655
Payments from drug & device makers
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$47,466,885in research payments, 2019–2025
Across 225 payments — averaging $210,964 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$33.9M
- Biogen$3.1M
- Amgen$2.8M
- Genentech, Inc.$1.4M
- Agios Pharmaceuticals, Inc.$1.3M
- Kadmon Corporation LLC$968K
- plus $4M from 7 others
How this compares
Too few clinical pharmacology providers in Texasto place this figure against a meaningful peer group, so we don't.
Other clinical pharmacology in Dallas
- Reginald EwesuedoSan Antonio$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.